PIK3CA and neoplasm: This analysis identified 100 cases (22.0%) with a PIK3CA mutation (Supplementary Fig. 1), a similar proportion to that seen in The Cancer Genome Atlas for these mutations in primary disease (22.1%)28, 29, PIK3CA mutations being predominantly truncal events in breast cancer30–34.